Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • INOVIQ’s breast cancer test outperforms leading approved test, plans for further validation
    • News

    INOVIQ’s breast cancer test outperforms leading approved test, plans for further validation

    Precision diagnostics company INOVIQ (ASX: IIQ) has achieved noteworthy results from an independent clinical validation study of its SubB2M/CA15-3 test for breast cancer detection. The study has reported high accuracy (87%), sensitivity (81%), and specificity (93%) for the test, outperforming a leading approved CA15-3 test. INOVIQ CEO, Dr Leearne Hinch, said, “The outstanding results from

    Read More
    Public
  • Bearish streak to come to an end?
    • Market Update

    Bearish streak to come to an end?

    The XJO is expected to edge higher on open this morning despite a small pullback in the U.S last night. Our market has certainly overshot to the downside in comparison to moves in the U.S lately, and also didn’t get to experience the broader rally they enjoyed over the past few months. This highlights the

    Read More
    Public
  • Can’t handle the heat: Tasfoods sells Shima Wasabi business to clear debt
    • News

    Can’t handle the heat: Tasfoods sells Shima Wasabi business to clear debt

    For wasabi lovers, the intense and pungent flavour is what draws them into taking a bite, and perhaps the burst of excitement and complexity to dishes are what keep them coming back. However, not everyone can handle the heat, and what if you can’t handle them from burning your nose? Same goes for TasFoods (ASX:

    Read More
    Public
  • Elsight receives $180k repeat order from Censys for its drone connectivity tech Halo
    • News

    Elsight receives $180k repeat order from Censys for its drone connectivity tech Halo

    If you are tired of hearing people drone on about the growth of drones over the past few years, prepare for it to not end anytime soon, seeing as drone tech is only advancing. Drone connectivity solutions company Elsight Limited (ASX: ELS) has received a repeat order from Censys Technologies Corporation, a leading US-based complete

    Read More
    Public
  • In low spirits: Lark Distilling forecasts $2 million sales decline citing inflationary pressure on booze
    • News

    In low spirits: Lark Distilling forecasts $2 million sales decline citing inflationary pressure on booze

    Aussie whisky and liquor company Lark Distilling Co (ASX: LRK) is not raising its glasses just yet, for growing inflationary pressures on households has left fewer people reaching out for a cold one. Lark reported a decline in its net sales for H2 FY23, forecast to be $7.4 million, down from $9.6 million in H1

    Read More
    Public
  • Selling in commodities, XJO to open flat
    • Market Update

    Selling in commodities, XJO to open flat

    The XJO is expected to open flat this morning following another pullback in the U.S on Friday and their positive futures this morning. We finished last week with our market wiping out over a week’s worth of gains in two big days of selling. This is likely why the small pullback in the U.S (coupled

    Read More
    Public
  • «
  • ‹
  • 224
  • 225
  • 226
  • 227
  • 228
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.